Correction: Additional information on the directed share issue.

In the press release published on April 16, 2019, the company announced that the new number of shares issued in the directed new issue was 1,217,556, which is incorrect. The correct number of shares issued is 1,252,617. In total, the number of shares after the transaction amounts to 79,235,625.

Below is the original text from the press release in question:

On April 10, the company announced that two proposed board members are investing SEK 9.6 million through a directed share issue. The company has received the payment. The price per share was set at SEK 7.64 in accordance with the communicated terms. The number of new shares issued to the proposed board members is 1,217,556 and the total number of shares after the transaction amounts to 79,200,564.

For further information, please contact:

Truls Sjöstedt, CEO
Phone: +46 709 73 46 00
E-mail: truls.sjostedt@brighter.se

Ann Zetterberg, CFO
Phone: +46 708 37 21 23
E-mail: ann.zetterberg@brighter.se

About Brighter AB (publ)
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop® - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. https://brighter.se/

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.